NABL vs. CLBT, LSPD, INST, MQ, COUR, AVPT, MTTR, ZETA, MLNK, and AMPL
Should you be buying N-able stock or one of its competitors? The main competitors of N-able include Cellebrite DI (CLBT), Lightspeed Commerce (LSPD), Instructure (INST), Marqeta (MQ), Coursera (COUR), AvePoint (AVPT), Matterport (MTTR), Zeta Global (ZETA), MeridianLink (MLNK), and Amplitude (AMPL). These companies are all part of the "prepackaged software" industry.
N-able (NYSE:NABL) and Cellebrite DI (NASDAQ:CLBT) are both mid-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.
96.4% of N-able shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 1.4% of N-able shares are owned by insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
N-able has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.
In the previous week, N-able had 9 more articles in the media than Cellebrite DI. MarketBeat recorded 12 mentions for N-able and 3 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.32 beat N-able's score of 0.47 indicating that Cellebrite DI is being referred to more favorably in the news media.
N-able presently has a consensus target price of $15.50, indicating a potential upside of 21.28%. Cellebrite DI has a consensus target price of $12.42, indicating a potential upside of 7.60%. Given N-able's higher probable upside, research analysts plainly believe N-able is more favorable than Cellebrite DI.
N-able has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than N-able, indicating that it is currently the more affordable of the two stocks.
N-able has a net margin of 6.27% compared to Cellebrite DI's net margin of -24.94%. Cellebrite DI's return on equity of 173.14% beat N-able's return on equity.
Cellebrite DI received 7 more outperform votes than N-able when rated by MarketBeat users. However, 62.07% of users gave N-able an outperform vote while only 53.19% of users gave Cellebrite DI an outperform vote.
Summary
N-able and Cellebrite DI tied by winning 9 of the 18 factors compared between the two stocks.
Get N-able News Delivered to You Automatically
Sign up to receive the latest news and ratings for NABL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NABL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
